DARIOHEALTH CORP
DRIONASDAQTrading Snapshot
- Day Range
- $1.26 β $1.65
- 52-Week Range
- $1.09 β $14.77
- Volume (shares)
- 28,213
- Avg Volume (shares)
- β
- Shares Outstanding
- 9.8M
- Next Earnings
- 2027-03-18
Fundamentals Snapshot
- Annual Revenue
- $22M
- Last Q Revenue
- $5M
- P/E Ratio
- β
- P/S Ratio
- 0.7x
- EPS (TTM)
- $-6.58
- Dividend Yield
- β
- Dilution (1yr)
- +22.8%
DARIOHEALTH CORP
DRIOAbout DARIOHEALTH CORP
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates

Dario CEO Erez Raphael to Lead Panel Discussion at U.S. Bancorp | BTIG Tech-Enabled Healthcare Forum
Erez Raphael will be joined by Personify Health President Ed Liebowitz for panel discussion on the evolving digital health market, including member choice, multi-condition care, engagement and ROI NEW YORK, Nov. 20, 2026

Dario and WebMD Health Services Announce Strategic Partnership to Deliver Dario's Multi-Condition Platform to Millions of Covered Lives
Extends Dario's reach to WebMD Health Services' 3,500 employers and 65 million lives covered Partnership combines WebMD ONE, a trusted engagement platform, with Dario's comprehensive AI-powered multi-condition platform a

Dario Secures Second Women's Health Contract in Just Weeks with The Minnesota Star Tribune
New agreement reflects rapid adoption of recently launched Dario Womenβ’, the Company's women's health solution addressing perimenopause and menopause The Minnesota Star Tribune expands its existing relationship with Dari

Dario Presents New Research at ISPOR Europe 2026 Validating a Biometric-Driven Approach to Estimating Healthcare Cost Savings and ROI - Consistent with Published Benchmarks and Without Waiting for Cla
Dario Presents New Research at ISPOR Europe 2026 Validating a Biometric-Driven Approach to Estimating Healthcare Cost Savings and ROI - Consistent with Publishe

Dario Presents New Research at ISPOR Europe 2026 Validating a Biometric-Driven Approach to Estimating Healthcare Cost Savings and ROI - Consistent with Published Benchmarks and Without Waiting for Claims Data
New methodology addresses critical market need for a transparent, replicable model to estimate healthcare cost savings andΒ ROI when medical claims data are unavailable or delayed Further demonstrates Dario's economic val

DarioHealth Corp. (DRIO) Q3 2026 Earnings Call Transcript
DarioHealth Corp. (DRIO) Q3 2026 Earnings Call Transcript